| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2018 | 2019 | 2020 | Q'20 | |
|---|---|---|---|---|
| Cash | 94.13 | 146.02 | 11.15 | 86.75 |
| Receivables | 245.08 | 205.15 | 107.25 | 80.72 |
| Inventory | 0.35 | 0.44 | — | — |
| Other | — | — | — | 15.24 |
| 339.56 | 351.60 | 118.41 | 182.71 |
| 2018 | 2019 | 2020 | Q'20 | |
|---|---|---|---|---|
| Payables | 72.14 | 83.49 | 90.94 | 171.22 |
| ST’ Debt | 151.96 | 208.91 | 116.86 | 100.21 |
| Other | 55.00 | 0.62 | 70.00 | 81.00 |
| 239.33 | 318.67 | 225.28 | 352.08 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Jun | Sep | Dec | Mar | Year | |
|---|---|---|---|---|---|
| ’26 | — | 144.14 | — | — |
—
|
| ’20 | 43.51 | 32.37 | 50.75 | 28.82 |
155.45
|
| ’19 | 60.21 | 63.43 | 76.74 | 69.75 |
270.13
|
| ’18 | 60.83 | 63.31 | 65.19 | 71.93 |
261.25
|
| ’17 | 71.10 | 71.88 | 57.35 | 52.68 |
252.99
|
| Jun | Sep | Dec | Mar | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’20 | 10.25 | (1.26) | (2.74) | 12.49 |
18.74
|
| ’19 | 15.12 | 1.70 | 23.76 | 34.38 |
74.97
|
| ’18 | 28.15 | (4.65) | 26.09 | 33.66 |
83.24
|
| ’17 | 18.90 | 32.08 | 42.35 | 5.67 |
98.99
|
| Jun | Sep | Dec | Mar | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’20 | (7.18) | (13.93) | (64.09) | 103.62 |
18.42
|
| ’19 | (0.51) | (37.50) | (1.43) | 112.43 |
73.69
|
| ’18 | (6.99) | (12.65) | (20.11) | (64.92) |
(104.68)
|
| ’17 | 1.01 | (9.02) | (67.88) | 0.72 |
(75.16)
|
| Jun | Sep | Dec | Mar | Year | |
|---|---|---|---|---|---|
| ’26 | — | (0.25) | — | — |
—
|
| ’20 | 0.60 | (5.60) | (3.20) | (69.80) |
(78.00)
|
| ’19 | (4.00) | 3.40 | 2.60 | (116.60) |
(119.80)
|
| ’18 | (0.40) | (0.60) | (1.80) | (6.20) |
(7.40)
|
| ’17 | 0.60 | (1.20) | 2.60 | (0.80) |
1.00
|
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Employees
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Gross Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
EBT
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
EBT Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Net Income
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Depreciation
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Revenue/Sh
|
| — | — | — | — | — | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Earnings/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Cash Flow/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ |
Book Value/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Shares
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PE Ratio
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
PB Ratio
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
EV/FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Working Cap'
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Net Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
Sh' Equity
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ |
ROA
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — |
ROIC
|
| — | — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
ROE
|
Eros Media World PLC (EMWP), once a Bollywood powerhouse, has clawed back from a near-death spiral—plummeting from mid-2010s glory to $514 million losses in 2020 amid COVID shutdowns, a botched $1 billion STX merger, delisting, and brutal dilution that shredded shareholder equity to a measly $0.35 BVPS. Yet 2023 flashed green with $18 million EBT on plunging $222 million revenue (down 71% from 2022 peak), resilient gross margins around 47%, and ROE spiking to 64.7%, hinting at a fragile phoenix rising via Eros Now’s digital pivot and library licensing.
The stock trades at a jaw-dropping 96-98% discount to analyst targets promising 4,300%+ upside, with bloated EV/Sales multiples betting on 20-30% CAGR—yet zero insider buys scream caution amid lingering STX arbitration risks, SEBI probes, and Bollywood’s capex-hungry OTT shift that could reignite debt flames. Revenue volatility, productivity swings, and FCF inconsistency expose the high-wire act: is this a contrarian steal or another media mirage?
Dive into the full analysis for the ratios, peer comps, and base-case projections that could turn EMWP into a multibagger—or validate the executive silence.
No news matches these filters.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.